[Federal Register Volume 79, Number 23 (Tuesday, February 4, 2014)]
[Rules and Regulations]
[Pages 6470-6475]
[FR Doc No: 2014-02223]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Parts 9 and 721

[EPA-HQ-OPPT-2012-0182; FRL-9399-1]
RIN 2070-AB27

Significant New Use Rule on Certain Chemical Substances

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: EPA is finalizing a significant new use rule (SNUR) under the
Toxic Substances Control Act (TSCA) for chemical substances identified
generically as complex strontium aluminate, rare earth doped, which
were the subject of several premanufacture notices (PMNs). This action
requires persons who intend to manufacture (including import) or
process any of the chemical substances for an activity that is
designated as a significant new use by this final rule to notify EPA at
least 90 days before commencing that activity. The required
notification would provide EPA with the opportunity to evaluate the
intended use and, if necessary, to prohibit or limit the activity
before it occurs.

DATES: This final rule is effective April 7, 2014.

ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPPT-2012-0182, is available at
http://www.regulations.gov or at the Office of Pollution Prevention and
Toxics Docket (OPPT Docket), Environmental Protection Agency Docket
Center (EPA/DC), EPA West Bldg., Rm. 3334, 1301 Constitution Ave. NW.,
Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30
p.m., Monday through Friday, excluding legal holidays. The telephone
number for the Public Reading Room is<PHONE_NUMBER>, and the telephone
number for the OPPT Docket is<PHONE_NUMBER>. Please review the visitor
instructions and additional information about the docket available at
http://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: For technical information contact:
Kenneth Moss, Chemical Control Division (7405M), Office of Pollution
Prevention and Toxics, Environmental Protection Agency, 1200
Pennsylvania Ave. NW., Washington, DC 20460-0001; telephone number:
(202) 564-9232; email address<EMAIL_ADDRESS>    For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Does this action apply to me?

    You may be potentially affected by this action if you manufacture,
process, or use the chemical substances contained in this final rule.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
     Manufacturers or processors of one or more subject
chemical substances (NAICS codes 325 and 324110), e.g., chemical
manufacturing and petroleum refineries.
    This action may also affect certain entities through pre-existing
import certification and export notification rules under TSCA. Chemical
importers are subject to the TSCA section 13 (15 U.S.C. 2612) import
certification requirements promulgated at 19 CFR

12.118 through 12.127 and 19 CFR 127.28. Chemical importers must
certify that the shipment of the chemical substance complies with all
applicable rules and orders under TSCA. Importers of chemicals subject
to these SNURs must certify their compliance with the SNUR
requirements. The EPA policy in support of import certification appears
at 40 CFR part 707, subpart B. In addition, any persons who export or
intend to export a chemical substance that is the subject of this final
rule are subject to the export notification provisions of TSCA section
12(b) (15 U.S.C. 2611(b)) (see Sec.  721.20), and must comply with the
export notification requirements in 40 CFR part 707, subpart D.

II. Background

A. What action is the agency taking?

    EPA is finalizing a SNUR under TSCA section 5(a)(2) for five
chemical substances which were the subject of PMNs. The five chemical
substances are all identified generically as complex strontium
aluminate, rare earth doped, which were the subject of PMNs P-12-22, P-
12-23, P-12-24, P-12-25, and P-12-26. This SNUR requires persons who
intend to manufacture or process any of these chemical substances for
an activity that is designated as a significant new use to notify EPA
at least 90 days before commencing that activity.
    In the Federal Register issue of April 25, 2012 (77 FR 24613) (FRL-
9345-4), EPA issued a direct final SNUR on these five chemical
substances in accordance with the procedures at Sec.  721.160(c)(3)(i).
EPA received notice of intent to submit adverse comments on this SNUR.
Therefore, as required by Sec.  721.160(c)(3)(ii), in the Federal
Register issue of June 22, 2012 (77 FR 37609) (FRL-9353-2), EPA
withdrew the direct final SNUR in a separate document, and subsequently
proposed a SNUR on the five chemical substances using notice and
comment procedures in the Federal Register issue of June 22, 2012 (77
FR 37634) (FRL-9353-3). More information on the specific chemical
substances subject to this final rule can be found in the Federal
Register documents announcing the direct final SNUR or the proposed
SNUR. The docket for the direct final SNUR on these chemical substances
was established as docket ID number EPA-HQ-OPPT-2012-0182. That docket
includes information considered by the Agency in developing the direct
final rule and this final rule, including comments on those rules. EPA
received several comments on the proposed rule. A full discussion of
EPA's response to these comments is included in Unit V. Based on these
comments, this final rule:
    1. Corrects the chemical identity of the PMN substances.
    2. Simplifies the description of the significant new use.

B. What is the agency's authority for taking this action?

    Section 5(a)(2) of TSCA (15 U.S.C. 2604(a)(2)) authorizes EPA to
determine that a use of a chemical substance is a ``significant new
use.'' EPA must make this determination by rule after considering all
relevant factors, including the four bulleted TSCA section 5(a)(2)
factors listed in Unit III. Once EPA determines that a use of a
chemical substance is a significant new use, TSCA section 5(a)(1)(B)
requires persons to submit a significant new use notice (SNUN) to EPA
at least 90 days before they manufacture or process the chemical
substance for that use. Persons who must report are described in Sec.
721.5.

C. Applicability of General Provisions

    General provisions for SNURs appear in 40 CFR part 721, subpart A.
These provisions describe persons subject to the rule, recordkeeping
requirements, exemptions to reporting requirements, and applicability
of the rule to uses occurring before the effective date of the rule.
Provisions relating to user fees appear at 40 CFR part 700. According
to Sec.  721.1(c), persons subject to these SNURs must comply with the
same SNUN requirements and EPA regulatory procedures as submitters of
PMNs under TSCA section 5(a)(1)(A). In particular, these requirements
include the information submission requirements of TSCA section 5(b)
and 5(d)(1), the exemptions authorized by TSCA section 5(h)(1), (h)(2),
(h)(3), and (h)(5), and the regulations at 40 CFR part 720. Once EPA
receives a SNUN, EPA may take regulatory action under TSCA section
5(e), 5(f), 6, or 7 to control the activities for which it has received
the SNUN. If EPA does not take action, EPA is required under TSCA
section 5(g) to explain in the Federal Register its reasons for not
taking action.

III. Rationale and Objectives of the Rule

A. Rationale

    During review of the PMNs submitted for these five chemical
substances, EPA determined that one or more of the criteria of concern
established at Sec.  721.170 were met, as discussed in Unit II. and IV.

B. Objectives

    EPA is issuing these SNURs for specific chemical substances which
have undergone premanufacture review because the Agency wants to
achieve the following objectives with regard to the significant new
uses designated in this final rule:
     EPA will receive notice of any person's intent to
manufacture or process a listed chemical substance for the described
significant new use before that activity begins.
     EPA will have an opportunity to review and evaluate data
submitted in a SNUN before the notice submitter begins manufacturing or
processing a listed chemical substance for the described significant
new use.
     EPA will be able to regulate prospective manufacturers or
processors of a listed chemical substance before the described
significant new use of that chemical substance occurs, provided that
regulation is warranted pursuant to TSCA sections 5(e), 5(f), 6, or 7.
     EPA can ensure that all manufacturers and processors of
the same chemical substance that is subject to a TSCA section 5(e)
consent order are subject to similar requirements.
    Issuance of a SNUR for a chemical substance does not signify that
the chemical substance is listed on the TSCA Chemical Substance
Inventory (TSCA Inventory). Guidance on how to determine if a chemical
substance is on the TSCA Inventory is available on the Internet at
http://www.epa.gov/opptintr/existingchemicals/pubs/tscainventory/index.html.

IV. Significant New Use Determination

    Section 5(a)(2) of TSCA states that EPA's determination that a use
of a chemical substance is a significant new use must be made after
consideration of all relevant factors, including:
     The projected volume of manufacturing and processing of a
chemical substance.
     The extent to which a use changes the type or form of
exposure of human beings or the environment to a chemical substance.
     The extent to which a use increases the magnitude and
duration of exposure of human beings or the environment to a chemical
substance.
     The reasonably anticipated manner and methods of
manufacturing, processing, distribution in commerce, and disposal of a
chemical substance.
    In addition to these factors enumerated in TSCA section 5(a)(2),
the statute requires EPA to consider any other relevant factors.
    To determine what would constitute a significant new use for the
five chemical

substances that are the subject of this SNUR, EPA considered relevant
information about the toxicity of the chemical substances, likely human
exposures and environmental releases associated with possible uses, and
the four bulleted TSCA section 5(a)(2) factors listed in this unit.

V. Response to Comments on Proposed SNUR

    A summary and discussion of the comments received on the proposed
rule and the Agency's response follow.
    Comment 1: The commenter noted that EPA incorrectly identified the
chemical substances as ``complex strontium aluminum, rare earth doped
(generic)'' in the proposed rule.
    EPA Response: EPA acknowledges the error and has corrected the
generic name to read: ``complex strontium aluminate, rare earth doped
(generic)''.
    Comment 2: The commenter stated the proposed significant new uses
are ongoing with respect to chemical substances very similar to the PMN
substances. Activated phosphors, including strontium aluminates similar
to the PMN substances, have been manufactured, processed, and used in
the United States for many years.
    EPA Response: Regardless of whether chemical substances similar to
the PMN substances are currently being used for purposes similar to the
significant new use proposed, such use is irrelevant to determining
ongoing use of the PMN substances for this rulemaking.
    Comment 3: The health and safety data on the PMN substances do not
justify a SNUR.
    EPA Response: EPA believes that these chemicals will act in the
respiratory tract similarly to other poorly soluble respirable
particles causing adverse lung effects. The submitter provided no
health and safety data information on the PMN substance or analogous
chemical substances. The commenter submitted no data refuting EPA's
concerns regarding poorly soluble respirable particles, as more than 5%
of the PMN substances particles are less than 10 microns. The SNUR is
therefore appropriate.
    Comment 4: The commenter stated that EPA did not properly consider
the four factors in TSCA section 5(a)(2) to determine that use of a
chemical substance is a significant new use, and reasonable
consideration of them shows that a SNUR is not justified for use of the
PMN substances. The commenter also contended that because chemical
substances similar to the PMN substances are widely manufactured
(including imported) and processed in the United States, and because
worker safety and environmental laws already apply to the PMN
substances, approval of the PMN substances without imposing a SNUR will
not increase the magnitude or duration of exposure of human beings or
the environment to the PMN substances because the scale of current use
is significantly larger than any potential increase of use without the
SNUR. The commenter also stated that strontium aluminates and titanium
dioxide are regulated by the Occupational Safety and Health
Administration (OSHA) as an inert or nuisance dust with a permissible
exposure limit (PEL) of 5 milligrams/cubic meter (mg/m\3\) and that the
level of exposure required for effects would not be a ``reasonably
anticipated condition of exposure.''
    EPA Response: Among the factors that must be considered under TSCA
section 5(a)(2) is ``(C) the extent to which a use increases the
magnitude and duration of exposure of human beings or the environment
to a chemical substance.'' This factor pertains to the potential
changes in exposure to a specific chemical substance, not to other,
possibly related, chemical substances which may have other exposure
patterns. EPA identified concerns for potential lung overload to
workers from inhalation exposure to the PMN substance based on
analogous respirable, poorly soluble particulate chemical substances
and predicts potential toxicity to workers from inhalation when more
than 5% of the PMN substances particles are less than 10 microns. The
fact that similar chemical substances are widely manufactured and
processed in the United States and that worker safety and environmental
laws apply to the PMN substance does not affect the potential for
change in magnitude and duration of exposure to the PMN substances that
are the subject of the SNUR. The commenter submitted no information to
alleviate EPA's concern, based on analogy to exposure patterns of other
respirable, poorly soluble particulates, that the significant new uses
(manufacture, process or use of the chemical substances where more than
5% of the particles are less than 10 microns) could increase the
magnitude and duration of exposure of human beings to respirable
particles of the PMN substances when greater than 5% of the PMN
substances particles are less than 10 microns. The OSHA PEL for
nuisance dust is 5 milligrams/cubic meter (mg/m\3\) respirable fraction
(OSHA, 29 CFR 1910.1000, Table Z-3). The change in particle size at the
reasonably anticipated levels of inhalation exposure to the PMN
substances, which is the PEL of 5 mg/m\3\, could result in potential
lung effects.
    Comment 5: The commenter stated that activated phosphors, including
strontium aluminates, have been subject to reporting under TSCA section
8(e) for many years, and is aware of no TSCA section 8(e) reports, and
EPA references no such reports in the regulations.gov for this docket.
The docket does not support that use of the strontium aluminate other
than as described in the PMNs may cause serious health effects.
    EPA Response: EPA acknowledges that it has not received TSCA
section 8(e) information for these chemical substances. However, the
fact that data has not been received does not demonstrate that hazards
for activated phosphors containing respirable particles do not exist,
just that none have been reported under TSCA section 8(e). Based on
analogous respirable and poorly soluble chemical substances, any use of
the chemical substances other than as described in the PMNs may cause
serious health effects to workers from inhalation when more than 5% of
the PMN substances particles are less than 10 microns.
    Comment 6: The commenter stated that EPA identified concerns
regarding potential lung overload to workers from inhalation exposure
to the PMN substance based on data for titanium oxide, and that
apparently based on these concerns, EPA found that changes in exposure
or release levels for ``any use of the substances other than as
described in the PMNs may cause serious health effects.'' The commenter
stated that the PMN substances are not closely analogous to titanium
oxide, however, and the docket contains no support for the conclusion
that their use other than as described in the PMNs would involve
changes in exposure or release levels that are significant in relation
to the health or environmental concerns in accordance with Sec.
721.170(c)(2)(ii). The commenter also stated that the data on titanium
oxide does not justify a SNUR for the PMN substances. Even if titanium
oxide were closely analogous to the PMN substances, the toxicological
data on titanium oxide are inconclusive.
    EPA Response: The Agency's concern for the PMN substances is based
on how these chemical substances will physically act in the respiratory
tract, not on chemical composition or how they chemically interact with
the respiratory tract. This concern is for the ability of the chemicals
to enter the deep lung via inhalation of small particles. The PMN
substances are

considered analogous in their physical properties to respirable, poorly
soluble particulates (RPSP). See ``TSCA New Chemicals Program Chemical
Categories,'' at http://www.epa.gov/oppt/newchems/pubs/npcchemicalcategories.pdf, for a discussion of these concerns. The RPSP
category identifies that there is potential for lung effects if workers
are exposed by inhalation to particles less than or equal to 10 microns
in diameter, based on five different types, or subcategories, of poorly
soluble particulates. Accordingly, the significant new use in this SNUR
is based on an increased exposure to particles less than 10 microns
which may cause lung effects. Each subcategory in the RPSP category
lists a New Chemicals Exposure Limit based on available information for
specific compounds. As is described in the RPSP category, EPA will also
consider the specific toxicity of the metal compound that is a
respirable poorly soluble particulate. However, no such data was
provided for the PMN substances. As there is no toxicity data available
on the PMN substances indicating potential for chemical toxicity, EPA
is considering only its attributes as a respirable, poorly soluble
particulate chemical substance. As a result, EPA believes the metal
oxide titanium dioxide subcategory is the appropriate subcategory based
on physical-chemical considerations. Adverse lung effects are
associated with the inhalation of crystalline metal compound
particulates. Crystalline particles more readily embed in lung alveolar
sacs than amorphous particles, and are difficult to clear with mucous
flow or coughing, leading to irritation and clogging of the sacs and
hampering of carbon dioxide-oxygen exchange in the lungs. EPA considers
the metal compound titanium dioxide to be a surrogate for most non-
silica, crystalline poorly soluble respirable metal compound
particulates, such as the PMN substances, that contain this type of
crystalline structure. This physical analogy with the metallic poorly
soluble respirable PMN substances is the primary driver in this case.
There are several studies, cited in the EPA's RPSP category, that
document lung effects from titanium dioxide exposure, and the RPSP
category also states that available data are inconclusive for
carcinogenicity effects from exposure to titanium dioxide. The National
Institute for Occupational Safety and Health (NIOSH) Current
Intelligence Bulletin 63: Occupational Exposure to Titanium Dioxide
(http://www.cdc.gov/niosh/docs/2011-160/pdfs/2011-160.pdf) also cites
data demonstrating lung effects from exposure to titanium dioxide.
    Comment 7: The definition of the significant new use is ambiguous
and, as drafted, could be interpreted to impose the proposed SNUR on
uses described in the PMN, referenced in Sec.  721.10423(a)(2). The
commenter would like EPA to change the language of the proposed rule to
make clear that the particle size limitation does not apply to the uses
of the strontium aluminates described in the PMN.
    EPA Response: Although Sec.  721.10423(a)(2) of the proposed rule
is correct as written, EPA agrees that the wording in the regulatory
text for Sec.  721.80(j) can be confusing. Therefore, EPA has
simplified the wording in the regulatory text to now read ``A
significant new use of the substance is a use other than manufacture,
processing, or use where no more than 5 percent of particles are less
than 10 microns.'' The SNUR would permit any use of the PMN substances
as long as the particle size limits are being met.

VI. Applicability of the Significant New Use Designation

    If uses begun after the proposed rule was published were considered
ongoing rather than new, any person could defeat the SNUR by initiating
the significant new use before the final rule was issued. Therefore,
EPA has designated the date of publication of the proposed rule as the
cutoff date for determining whether the new use is ongoing. See the
Federal Register notice of April 24, 1990 (55 FR 17376) (FRL-3658-5)
for a more detailed discussion of the cutoff date for ongoing uses. Any
person who began commercial manufacture, import, or processing of the
chemical substances identified generically as complex strontium
aluminate, rare earth doped, which were the subject of PMNs P-12-22, P-
12-23, P-12-24, P-12-25, and P-12-26 for any of the significant new
uses, designated in the proposed SNUR after the date of publication of
the proposed SNUR, must stop that activity before the effective date of
the final rule. Persons who ceased those activities will have to first
comply with all applicable SNUR notification requirements, and wait
until the notice review period, including any extensions, expires,
before engaging in any activities designated as significant new uses.
If a person were to meet the conditions of advance compliance under
Sec.  721.45(h), the person would be considered to have met the
requirements of the final SNUR for those activities.

VII. Test Data and Other Information

    EPA recognizes that TSCA section 5 does not require developing any
particular test data before submission of a SNUN. The two exceptions
are:
    1. Development of test data is required where the chemical
substance subject to the SNUR is also subject to a test rule under TSCA
section 4 (see TSCA section 5(b)(1)).
    2. Development of test data may be necessary where the chemical
substance has been listed under TSCA section 5(b)(4) (see TSCA section
5(b)(2)).
    In the absence of a TSCA section 4 test rule, or a TSCA section
5(b)(4) listing covering the chemical substance, persons are required
only to submit test data in their possession or control and to describe
any other data known to or reasonably ascertainable by them (see 40 CFR
720.50). However, upon review of PMNs and SNUNs, EPA has the authority
to require appropriate testing. Unit IV. of the proposed rule lists the
testing recommended by EPA. Specifically, EPA has determined that a 90-
day inhalation toxicity test (OPPTS Test Guideline 870.3465) would help
characterize the human health effects of the PMN substances.
Descriptions of tests are provided for informational purposes. EPA
strongly encourages persons, before performing any testing, to consult
with the Agency pertaining to protocol selection and test selection. To
access the OCSPP test guidelines referenced in this document
electronically, please go to http://www.epa.gov/ocspp and select ``Test
Methods and Guidelines.''
    The recommended tests may not be the only means of addressing the
potential risks of the chemical substance. However, submitting a SNUN
without any test data may increase the likelihood that EPA will take
action under TSCA section 5(e), particularly if satisfactory test
results have not been obtained from a prior PMN or SNUN submitter. EPA
recommends that potential SNUN submitters contact EPA early enough so
that they will be able to conduct the appropriate tests.
    SNUN submitters should be aware that EPA will be better able to
evaluate SNUNs which provide detailed information on the following:
     Human exposure and environmental release that may result
from the significant new use of the chemical substances.
     Potential benefits of the chemical substances.
     Information on risks posed by the chemical substances
compared to risks posed by potential substitutes.

VIII. SNUN Submissions

    According to Sec.  721.1(c), persons submitting a SNUN must comply
with the same notification requirements and EPA regulatory procedures
as persons submitting a PMN, including submission of test data on
health and environmental effects as described in 40 CFR 720.50. SNUNs
must be submitted on EPA Form No. 7710-25, generated using e-PMN
software, and submitted to the Agency in accordance with the procedures
set forth in Sec.  721.25 and 40 CFR 720.40. E-PMN software is
available electronically at http://www.epa.gov/opptintr/newchems.

IX. Economic Analysis

    EPA has evaluated the potential costs of establishing SNUN
requirements for potential manufacturers and processors of the chemical
substances subject to this final rule. EPA's complete economic analysis
is available in the docket under docket ID number EPA-HQ-OPPT-2012-
0182.

X. Statutory and Executive Order Reviews

A. Executive Order 12866

    This final rule establishes a SNUR for 5 chemical substances that
were the subject of PMNs. The Office of Management and Budget (OMB) has
exempted these types of actions from review under Executive Order
12866, entitled ``Regulatory Planning and Review'' (58 FR 51735,
October 4, 1993).

B. Paperwork Reduction Act (PRA)

    According to PRA (44 U.S.C. 3501 et seq.), an Agency may not
conduct or sponsor, and a person is not required to respond to a
collection of information that requires OMB approval under PRA, unless
it has been approved by OMB and displays a currently valid OMB control
number. The OMB control numbers for EPA's regulations in title 40 of
the CFR, after appearing in the Federal Register, are listed in 40 CFR
part 9, and included on the related collection instrument or form, if
applicable. EPA is amending the table in 40 CFR part 9 to list the OMB
approval number for the information collection requirements contained
in this final rule. This listing of the OMB control numbers and their
subsequent codification in the CFR satisfies the display requirements
of PRA and OMB's implementing regulations at 5 CFR part 1320. This
Information Collection Request (ICR) was previously subject to public
notice and comment prior to OMB approval, and given the technical
nature of the table, EPA finds that further notice and comment to amend
it is unnecessary. As a result, EPA finds that there is ``good cause''
under section 553(b)(3)(B) of the Administrative Procedure Act (5
U.S.C. 553(b)(3)(B)) to amend this table without further notice and
comment.
    The information collection requirements related to this action have
already been approved by OMB pursuant to PRA under OMB control number
2070-0012 (EPA ICR No. 574). This action does not impose any burden
requiring additional OMB approval. If an entity were to submit a SNUN
to the Agency, the annual burden is estimated to average between 30 and
170 hours per response. This burden estimate includes the time needed
to review instructions, search existing data sources, gather and
maintain the data needed, and complete, review, and submit the required
SNUN.
    Send any comments about the accuracy of the burden estimate, and
any suggested methods for minimizing respondent burden, including
through the use of automated collection techniques, to the Director,
Collection Strategies Division, Office of Environmental Information
(2822T), Environmental Protection Agency, 1200 Pennsylvania Ave. NW.,
Washington, DC 20460-0001. Please remember to include the OMB control
number in any correspondence, but do not submit any completed forms to
this address.

C. Regulatory Flexibility Act (RFA)

    On February 18, 2012, EPA certified pursuant to RFA section 605(b)
(5 U.S.C. 601 et seq.), that promulgation of a SNUR does not have a
significant economic impact on a substantial number of small entities
where the following are true:
    1. A significant number of SNUNs would not be submitted by small
entities in response to the SNUR.
    2. The SNUN submitted by any small entity would not cost
significantly more than $8,300.
    A copy of that certification is available in the docket for this
final rule.
    This final rule is within the scope of the February 18, 2012,
certification. Based on the Economic Analysis discussed in Unit IX. and
EPA's experience promulgating SNURs (discussed in the certification),
EPA believes that the following are true:
     A significant number of SNUNs would not be submitted by
small entities in response to the SNUR.
     Submission of the SNUN would not cost any small entity
significantly more than $8,300. Therefore, the promulgation of the SNUR
would not have a significant economic impact on a substantial number of
small entities.

D. Unfunded Mandates Reform Act (UMRA)

    Based on EPA's experience with proposing and finalizing SNURs,
State, local, and Tribal governments have not been impacted by these
rulemakings, and EPA does not have any reasons to believe that any
State, local, or Tribal government will be impacted by this final rule.
As such, EPA has determined that this final rule does not impose any
enforceable duty, contain any unfunded mandate, or otherwise have any
effect on small governments subject to the requirements of UMRA
sections 202, 203, 204, or 205 (2 U.S.C. 1501 et seq.).

E. Executive Order 13132

    This action will not have a substantial direct effect on States, on
the relationship between the national government and the States, or on
the distribution of power and responsibilities among the various levels
of government, as specified in Executive Order 13132, entitled
``Federalism'' (64 FR 43255, August 10, 1999).

F. Executive Order 13175

    This final rule does not have Tribal implications because it is not
expected to have substantial direct effects on Indian Tribes. This
final rule does not significantly nor uniquely affect the communities
of Indian Tribal governments, nor does it involve or impose any
requirements that affect Indian Tribes. Accordingly, the requirements
of Executive Order 13175, entitled ``Consultation and Coordination with
Indian Tribal Governments'' (65 FR 67249, November 9, 2000), do not
apply to this final rule.

G. Executive Order 13045

    This action is not subject to Executive Order 13045, entitled
``Protection of Children from Environmental Health Risks and Safety
Risks'' (62 FR 19885, April 23, 1997), because this is not an
economically significant regulatory action as defined by Executive
Order 12866, and this action does not address environmental health or
safety risks disproportionately affecting children.

H. Executive Order 13211

    This action is not subject to Executive Order 13211, entitled
``Actions Concerning Regulations That Significantly Affect Energy
Supply, Distribution, or Use'' (66 FR 28355, May 22, 2001), because
this action is not expected to affect energy supply, distribution, or
use and because this

action is not a significant regulatory action under Executive Order
12866.

I. National Technology Transfer and Advancement Act (NTTAA)

    In addition, since this action does not involve any technical
standards, NTTAA section 12(d) (15 U.S.C. 272 note), does not apply to
this action.

J. Executive Order 12898

    This action does not entail special considerations of environmental
justice related issues as delineated by Executive Order 12898, entitled
``Federal Actions to Address Environmental Justice in Minority
Populations and Low-Income Populations'' (59 FR 7629, February 16,
1994).

XI. Congressional Review Act (CRA)

    Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).

List of Subjects

40 CFR Part 9

    Environmental protection, Reporting and recordkeeping requirements.

40 CFR Part 721

    Environmental protection, Chemicals, Hazardous substances,
Reporting and recordkeeping requirements.

    Dated: January 20, 2014.
Maria J. Doa,
Director, Chemical Control Division, Office of Pollution Prevention and
Toxics.
    Therefore, 40 CFR parts 9 and 721 are amended as follows:

PART 9--[AMENDED]

0
1. The authority citation for part 9 continues to read as follows:

    Authority:  7 U.S.C. 135 et seq., 136-136y; 15 U.S.C. 2001,
2003, 2005, 2006, 2601-2671; 21 U.S.C. 331j, 346a, 348; 31 U.S.C.
9701; 33 U.S.C. 1251 et seq., 1311, 1313d, 1314, 1318, 1321, 1326,
1330, 1342, 1344, 1345(d) and (e), 1361; E.O. 11735, 38 FR 21243, 3
CFR, 1971-1975 Comp. p. 973; 42 U.S.C. 241, 242b, 243, 246, 300f,
300g, 300g-1, 300g-2, 300g-3, 300g-4, 300g-5, 300g-6, 300j-1, 300j-
2, 300j-3, 300j-4, 300j-9, 1857 et seq., 6901-6992k, 7401-7671q,
7542, 9601-9657, 11023, 11048.

0
2. In Sec.  9.1, add the following section in numerical order under the
undesignated center heading ``Significant New Uses of Chemical
Substances'' to read as follows:

Sec.  9.1  OMB approvals under the Paperwork Reduction Act.

* * * * *

------------------------------------------------------------------------
          40 CFR citation                      OMB Control No.
------------------------------------------------------------------------

------------------------------------------------------------------------
                               * * * * *
               Significant New Uses of Chemical Substances
------------------------------------------------------------------------

                                * * * * *
                721.10423                            2070-0012

                                * * * * *
------------------------------------------------------------------------

* * * * *

PART 721--[AMENDED]

0
3. The authority citation for part 721 continues to read as follows:

    Authority:  15 U.S.C. 2604, 2607, and 2625(c).

0
4. Add Sec.  721.10423 to subpart E to read as follows:

Sec.  721.10423  Complex strontium aluminate, rare earth doped
(generic).

    (a) Chemical substances and significant new uses subject to
reporting. (1) The chemical substances identified generically as
complex strontium aluminate, rare earth doped (PMNs P-12-22, P-12-23,
P-12-24, P-12-25, and P-12-26) are subject to reporting under this
section for the significant new uses described in paragraph (a)(2) of
this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. A significant
new use of the substance is a use other than manufacture, processing,
or use where no more than 5 percent of particles are less than 10
microns.
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a), (b), (c), and (i) are applicable to manufacturers,
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

[FR Doc. 2014-02223 Filed 2-3-14; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 82, Number 111 (Monday, June 12, 2017)]
[Notices]
[Pages 26937-26939]
[FR Doc No: 2017-12104]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-N-0618]

Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Electronic Products

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by July
12, 2017.

ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX:<PHONE_NUMBER>, or emailed to<EMAIL_ADDRESS>All
comments should be identified with the OMB control number 0910-0025.
Also include the FDA docket number found in brackets in the heading of
this document.

FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of
Operations, Food and Drug Administration, Three White Flint North
10A63, 11601 Landsdown St., North Bethesda, MD 20852,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.

Electronic Products OMB Control Number 0910-0025--Reinstatement

    Under sections 532 through 542 of the Federal Food, Drug, and
Cosmetic Act (the FD&C Act) (21 U.S.C. 360ii through 360ss), FDA has
the responsibility to protect the public from unnecessary exposure of
radiation from electronic products. The regulations issued under these
authorities are listed in Title 21 of the Code of Federal Regulations,
chapter I, subchapter J, parts 1000 through 1050 (21 CFR parts 1000
through 1050).
    Section 532 of the FD&C Act directs the Secretary of Health and
Human Services (the Secretary), to establish and carry out an
electronic product radiation control program, including the
development, issuance, and administration of performance standards to
control the emission of electronic product radiation from electronic
products. The program is designed to protect the public health and
safety from electronic radiation, and the FD&C Act authorizes the
Secretary to procure (by negotiation or otherwise) electronic products
for research and testing purposes and to sell or otherwise dispose of
such products. Section 534(g) of the FD&C Act directs the Secretary to
review and evaluate industry testing programs on a continuing basis;
and section 535(e) and (f) of the FD&C Act directs the Secretary to
immediately notify manufacturers of, and ensure correction of,
radiation defects or noncompliance with performance standards. Section
537(b) of the FD&C Act contains the authority to require manufacturers
of electronic products to establish and maintain records (including
testing records), make reports, and provide information to determine
whether the manufacturer has acted in compliance.
    The regulations under parts 1002 through 1010 specify reports to be
provided by manufacturers and distributors to FDA and records to be
maintained in the event of an investigation of a safety concern or a
product recall. FDA conducts laboratory compliance testing of products
covered by regulations for product standards in parts 1020, 1030, 1040,
and 1050.
    FDA details product-specific performance standards that specify
information to be supplied with the product or require specific
reports. The information collections are either specifically called for
in the FD&C Act or were developed to aid the Agency in performing its
obligations under the FD&C Act. The data reported to FDA and the
records maintained are used by FDA and the industry to make decisions
and take actions that protect the public from radiation hazards
presented by electronic products. This information refers to the
identification of, location of, operational characteristics of, quality
assurance programs for, and problem identification and correction of
electronic products. The data provided to users and others are intended
to encourage actions to reduce or eliminate radiation exposures.
    FDA uses the following forms to aid respondents in the submission
of information for this information collection:

Form FDA 2579 ``Report of Assembly of a Diagnostic X-Ray System''
Form FDA 2767 ``Notice of Availability of Sample Electronic
Product''
Form FDA 2877 ``Declaration for Imported Electronic Products Subject
to Radiation Control Standards''
Form FDA 3649 ``Accidental Radiation Occurrence (ARO)''
Form FDA 3626 ``A Guide for the Submission of Initial Reports on
Diagnostic X-Ray Systems and Their Major Components''
Form FDA 3627 ``Diagnostic X-Ray CT Products Radiation Safety
Report''
Form FDA 3628 ``General Annual Report (Includes Medical, Analytical,
and Industrial X-Ray Products Annual Report)''
Form FDA 3629 ``Abbreviated Report''
Form FDA 3630 ``Guide for Preparing Product Reports on Sunlamps and
Sunlamp Products''
Form FDA 3631 ``Guide for Preparing Annual Reports on Radiation
Safety Testing of Sunlamp Products''
Form FDA 3632 ``Guide for Preparing Product Reports on Lasers and
Products Containing Lasers''
Form FDA 3633 ``General Variance Request''
Form FDA 3634 ``Television Products Annual Report''
Form FDA 3635 ``Laser Light Show Notification''
Form FDA 3636 ``Guide for Preparing Annual Reports on Radiation
Safety Testing of Laser and Laser Light Show Products''
Form FDA 3637 ``Laser Original Equipment Manufacturer (OEM) Report''
Form FDA 3638 ``Guide for Filing Annual Reports for X-Ray Components
and Systems''
Form FDA 3639 ``Guidance for the Submission of Cabinet X-Ray System
Reports Pursuant to 21 CFR 1020.40''
Form FDA 3640 ``Reporting Guide for Laser Light Shows and Displays''
Form FDA 3147 ``Application for a Variance From 21 CFR 1040.11(c)
for a Laser Light Show, Display, or Device''
Form FDA 3641 ``Cabinet X-Ray Annual Report''
Form FDA 3642 ``General Correspondence''
Form FDA 3643 ``Microwave Oven Products Annual Report''
Form FDA 3644 ``Guide for Preparing Product Reports for Ultrasonic
Therapy Products''
Form FDA 3645 ``Guide for Preparing Annual Reports for Ultrasonic
Therapy Products''
Form FDA 3646 ``Mercury Vapor Lamp Products Radiation Safety
Report''
Form FDA 3647 ``Guide for Preparing Annual Reports on Radiation
Safety Testing of Mercury Vapor Lamps''
Form FDA 3659 ``Reporting and Compliance Guide for Television
Products''
Form FDA 3660 ``Guidance for Preparing Reports on Radiation Safety
of Microwave Ovens''
Form FDA 3661 ``A Guide for the Submission of an Abbreviated Report
on X-Ray Tables, Cradles, Film Changers or Cassette Holders Intended
for Diagnostic Use''

Form FDA 3662 ``A Guide for the Submission of an Abbreviated
Radiation Safety Report on Cephalometric Devices Intended for
Diagnostic Use''
Form FDA 3663 ``Abbreviated Reports on Radiation Safety for
Microwave Products (Other than Microwave Ovens)''
Form FDA 3801 ``Guide for Preparing Initial Reports and Model Change
Reports on Medical Ultraviolet Lamps and Products Containing Such
Lamps''

    The respondents to this information collection are electronic
product and x-ray manufacturers, importers, and assemblers. The burden
estimates were derived by consultation with FDA and industry personnel,
and are based on data collected from industry, including recent product
report submissions. An evaluation of the type and scope of information
requested was also used to derive some time estimates.
    In the Federal Register of November 10, 2016 (81 FR 79030), FDA
published a 60-day notice requesting public comment on the proposed
collection of information.
    FDA received five comments relating to potential changes to the
process by which the FDA distributes and collects Form FDA 2579,
``Report of Assembly of a Diagnostic X-Ray System.'' While these
comments were not responsive to the four information collection-related
topics on which we requested comment, FDA would like to provide
assurance that these comments have been noted and are being considered
as part of FDA's efforts to review the process by which Form FDA 2579
is distributed and collected.
    FDA estimates the burden of this collection of information as
follows:

                                                     Table 1--Estimated Annual Reporting Burden 1 2
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                Number of
                                                                      Number of    responses      Total
        Activity/21 CFR section                 FDA form No.         respondents      per         annual      Average burden per response    Total hours
                                                                                respondent   responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Product reports--1002.10(a) through (k)  3626--Diagnostic x-ray;           1,400          2.2        3,080  24.............................       73,920
                                          3627--CT x-ray; 3639--
                                          Cabinet x-ray; 3632--
                                          Laser; 3640--Laser light
                                          show; 3630--Sunlamp;
                                          3646--Mercury vapor lamp;
                                          3644--Ultrasonic therapy;
                                          3659--TV; 3660--Microwave
                                          oven; 3801--UV lamps.
Product safety or testing changes--      ..........................          480          2.5        1,200  .5 (30 minutes)................          600
 1002.11(a) and (b).
Abbreviated reports--1002.12...........  3629--General abbreviated            60          1.8          108  5..............................          540
                                          report; 3661--X-ray
                                          tables, etc.; 3662--
                                          Cephalometric device;
                                          3663--Microwave products
                                          (non-oven).
Annual reports--1002.13(a) and (b).....  3628--General; 3634--TV;          1,660          1.3        2,158  18.............................       38,844
                                          3638--Diagnostic x-ray;
                                          3641--Cabinet x-ray;
                                          3643--Microwave oven;
                                          3636--Laser; 3631--
                                          Sunlamp; 3647--Mercury
                                          vapor lamp; 3645--
                                          Ultrasonic therapy.
Quarterly updates for new models--       ..........................          120          1.4          168  .5 (30 minutes)................           84
 1002.13(c).
Accidental radiation occurrence          3649--ARO.................           30          6.7          201  2..............................          402
 reports--1002.20.
Exemption requests--1002.50(a) and       3642--General                         4          1.3            5  1..............................            5
 1002.51.                                 correspondence.
Product and sample information--1005.10  2767--Sample product......            5            1            5  .1 (6 minutes).................            1
Identification information and           2877--Imports declaration.       12,620          2.5       31,550  .2 (12 minutes)................        6,310
 compliance status--1005.25.
Alternate means of certification--       ..........................            1            2            2  5..............................           10
 1010.2(d).
Variance--1010.4(b)....................  3633--General variance              350          1.1          385  1.2............................          462
                                          request; 3147--Laser show
                                          variance request; 3635--
                                          Laser show notification.
Exemption from performance standards--   ..........................            1            1            1  22.............................           22
 1010.5(c) and (d).
Alternate test procedures--1010.13.....  ..........................            1            1            1  10.............................           10
Report of assembly of diagnostic x-ray   2579--Assembler report....        1,230           34       41,820  .30 (18 minutes)...............       12,546
 components--1020.30(d), (d)(1), and
 (2).
Microwave oven exemption from warning    ..........................            1            1            1  1..............................            1
 labels--1030.10(c)(6)(iv).
Laser products registration--            3637--OEM report..........           70          2.9          203  3..............................          609
 1040.10(a)(3)(i).
                                                                    ------------------------------------------------------------------------------------
    Total..............................  ..........................  ...........  ...........  ...........  ...............................      134,366
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
\2\ Numbers have been rounded.

                                                   Table 2--Estimated Annual Recordkeeping Burden 1 2
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                    Number of
            Activity/21 CFR section                 Number of      records per    Total annual       Average burden per recordkeeping       Total hours
                                                  recordkeepers   recordkeeper       records
--------------------------------------------------------------------------------------------------------------------------------------------------------
Manufacturers records--1002.30 and 1002.31(a)..           1,650           1,650       2,722,500  .12 (7 minutes)........................         326,700
Dealer/distributor records--1002.40 and 1002.41           3,110              50         155,500  .05 (3 minutes)........................           7,775
Information on diagnostic x-ray systems--                    50               1              50  .5 (30 minutes)........................              25
 1020.30(g).

Laser products distribution records--                        70               1              70  1......................................              70
 1040.10(a)(3)(ii).
                                                --------------------------------------------------------------------------------------------------------
    Total......................................  ..............  ..............  ..............  .......................................         334,570
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
\2\ Numbers have been rounded.

                           Table 3--Estimated Annual Third-Party Disclosure Burden 1 2
----------------------------------------------------------------------------------------------------------------
                                                     Number of
     Activity/21 CFR section         Number of      disclosures    Total annual   Average burden    Total hours
                                    respondents   per respondent    disclosures   per disclosure
----------------------------------------------------------------------------------------------------------------
Technical and safety information               1               1               1              12              12
 for users--1002.3..............
Dealer/distributor records--                  30               3              90               1              90
 1002.40 and 1002.41............
Television receiver critical                   1               1               1               1               1
 component warning--
 1020.10(c)(4)..................
Cold-cathode tubes--                           1               1               1               1               1
 1020.20(c)(4)..................
Information on diagnostic x-ray                6               1               6              55             330
 systems--1020.30(g)............
Statement of maximum line                      6               1               6              10              60
 current of x-ray systems--
 1020.30(g)(2)..................
Diagnostic x-ray system safety                 6               1               6             200           1,200
 and technical information--
 1020.30(h)(1) through (4)......
Fluoroscopic x-ray system safety               5               1               5              25             125
 and technical information--
 1020.30(h)(5) and (6) and
 1020.32(a)(1), (g), and (j)(4).
CT equipment--1020.33(c), (d),                 5               1               5             150             750
 (g)(4), and (j)................
Cabinet x-ray systems                          6               1               6              40             240
 information--1020.40(c)(9)(i)
 and (ii).......................
Microwave oven radiation safety                1               1               1              20              20
 instructions--1030.10(c)(4)....
Microwave oven safety                          1               1               1              20              20
 information and instructions--
 1030.10(c)(5)(i) through (iv)..
Microwave oven warning labels--                1               1               1               1               1
 1030.10(c)(6)(iii).............
Laser products information--                   3               1               3              20              60
 1040.10(h)(1)(i) through (vi)..
Laser product service                          3               1               3              20              60
 information--1040.10(h)(2)(i)
 and (ii).......................
Medical laser product                          2               1               2              10              20
 instructions--1040.11(a)(2)....
Sunlamp products instructions--                1               1               1              10              10
 1040.20........................
Mercury vapor lamp labeling--                  1               1               1               1               1
 1040.30(c)(1)(ii)..............
Mercury vapor lamp permanently                 1               1               1               1               1
 affixed labels--1040.30(c)(2)..
Ultrasonic therapy products--                  1               1               1              56              56
 1050.10(d)(1) through (4),
 (f)(1), and (f)(2)(iii)........
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............           3,058
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.
\2\ Numbers have been rounded.

    Dated: May 25, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-12104 Filed 6-9-17; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 88, Number 41 (Thursday, March 2, 2023)]
[Notices]
[Pages 13134-13135]
[FR Doc No: 2023-04277]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-4684-DR; Docket ID FEMA-2023-0001]

Alabama; Major Disaster and Related Determinations

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a notice of the Presidential declaration of a major
disaster for the State of Alabama (FEMA-4684-DR), dated January 15,
2023, and related determinations.

DATES: The declaration was issued January 15, 2023.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street SW,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: Notice is hereby given that, in a letter
dated January 15, 2023, the President issued a major disaster
declaration under the authority of the Robert T. Stafford Disaster
Relief and Emergency Assistance Act, 42 U.S.C. 5121 et seq. (the
``Stafford Act''), as follows:

    I have determined that the damage in the State of Alabama
resulting from severe storms, straight-line winds, and tornadoes on
January 12, 2023, is of sufficient severity and magnitude to warrant
a major disaster declaration under the Robert T. Stafford Disaster
Relief and Emergency Assistance Act, 42 U.S.C. 5121 et seq. (the
``Stafford Act''). Therefore, I declare that such a major disaster
exists in the State of Alabama.
    In order to provide Federal assistance, you are hereby
authorized to allocate from funds available for these purposes such
amounts as you find necessary for Federal disaster assistance and
administrative expenses.
    You are authorized to provide Individual Assistance, assistance
for debris removal and emergency protective measures (Categories A
and B) under the Public Assistance program in the designated areas,
Hazard Mitigation throughout the State, and any other forms of
assistance under the Stafford Act that you deem appropriate subject
to completion of Preliminary Damage Assessments (PDAs).
    Consistent with the requirement that Federal assistance is
supplemental, any

Federal funds provided under the Stafford Act for Public Assistance,
Hazard Mitigation, and Other Needs Assistance under section 408 will
be limited to 75 percent of the total eligible cost.
    Further, you are authorized to make changes to this declaration
for the approved assistance to the extent allowable under the
Stafford Act.

    The time period prescribed for the implementation of section
310(a), Priority to Certain Applications for Public Facility and Public
Housing Assistance, 42 U.S.C. 5153, shall be for a period not to exceed
six months after the date of this declaration.
    The Federal Emergency Management Agency (FEMA) hereby gives notice
that pursuant to the authority vested in the Administrator, under
Executive Order 12148, as amended, Kevin A. Wallace, Sr., of FEMA is
appointed to act as the Federal Coordinating Officer for this major
disaster.
    The following areas of the State of Alabama have been designated as
adversely affected by this major disaster:

    Autauga and Dallas Counties for Individual Assistance.
    Autauga and Dallas Counties for debris removal and emergency
protective measures (Categories A and B) under the Public Assistance
program.
    All areas within the State of Alabama are eligible for
assistance under the Hazard Mitigation Grant Program.
    The following Catalog of Federal Domestic Assistance Numbers
(CFDA) are to be used for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis
Counseling; 97.033, Disaster Legal Services; 97.034, Disaster
Unemployment Assistance (DUA); 97.046, Fire Management Assistance
Grant; 97.048, Disaster Housing Assistance to Individuals and
Households In Presidentially Declared Disaster Areas; 97.049,
Presidentially Declared Disaster Assistance--Disaster Housing
Operations for Individuals and Households; 97.050, Presidentially
Declared Disaster Assistance to Individuals and Households--Other
Needs; 97.036, Disaster Grants--Public Assistance (Presidentially
Declared Disasters); 97.039, Hazard Mitigation Grant.

Deanne Criswell,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2023-04277 Filed 3-1-23; 8:45 am]
BILLING CODE 9111-23-P